Gentaur Pub

#22237896   // Save this To Up

Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus.

Enzyme-linked immunosorbent assay (ELISA) is normally used to quantify the amount of serum IgG antibodies against measles, mumps, rubella, and varicella-zoster virus (MMRV). However, this method is time- and material-consuming. Therefore, a multiplex immunoassay for the simultaneous quantitative detection of antibodies against MMRV was developed. In-house as well as commercially available antigens can be used, making the assay available for all laboratories. The multiplex assay is much more sensitive than the separate ELISAs and has a high specificity, and only 5 μl of serum is needed. Heterologous inhibition did not exceed 11.5%, while homologous inhibition varied between 91.3 and 97.9%. Good correlations with the in-house ELISAs for measles (R(2) = 0.98), mumps (R(2) = 0.97), and rubella (R(2) = 0.97) virus as well as with the ELISA kit for varicella-zoster virus (R(2) = 0.95) were obtained. In conclusion, the MMRV multiplex assay is a good alternative to the conventional ELISAs and suitable for use in serosurveillance and vaccine studies.

2173 related Products with: Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus.

MOUSE ANTI CANINE DISTEMP Human Serum Albumin antib Hepatitis C Virus antibod Goat Anti-Rubella Virus A Hepatitis A Virus antibod Goat Anti-Rubella Virus A Hepatitis C Virus antibod Mouse Anti-Rubeola Virus Measles Virus nucleoprote MarkerGeneTM Fluorescent Human Serum Albumin antib Mouse Anti-Rubella Virus

Related Pathways

#17368781   // Save this To Up

Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.

Varicella is a highly infectious disease caused by varicella-zoster virus (VZV). The aim of this study was to explore the geographical difference of VZV antibody seroprevalence among children in private vaccination areas in Taiwan, controlling for potential factors relating to varicella susceptibility.

2765 related Products with: Analysis of factors associated with varicella-zoster virus susceptibility among children 0-12 years old in Taiwan.

Varicella Zoster Virus (V Varicella Zoster Virus (V Varicella Zoster Virus (V Human Varicella zoster vi Mouse Anti-Influenza A Vi Mouse Anti-Influenza B Vi Recombinant Influenza (H5 Native Influenza HA (A Ta HA (Influenza A Virus Hem Native Influenza A Virus Vertical Laminar Flow Cle Avian Influenza Virus H5N

Related Pathways

#17290724   // Save this To Up

Seroprevalence of antibody to varicella among Somali refugees.

To determine the seroprevalence of varicella antibody among recent Somali refugees living in Olmsted County, Minnesota, and to estimate the risk of varicella-zoster virus (VZV) infection in this group.

2413 related Products with: Seroprevalence of antibody to varicella among Somali refugees.

Analysis Tool for AAM-INF Diphtheria toxin antibody Analysis Tool for AAH-ANG Analysis Tool for AAH-CYT Shiga Toxin 1 antibody, M Analysis Tool for AAH-CYT Analysis Tool for AAH-CYT Analysis Tool for AAH-MMP Analysis Tool for AAM-ATH Analysis Tool for AAM-CYT Analysis Tool for AAM-CYT Analysis Tool for AAR-CYT

Related Pathways

#16459000   // Save this To Up

Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.

To investigate the persistence of maternal IgG antibodies against Varicella-Zoster virus (VZV) in infants and young children.

1604 related Products with: Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.

Goat Anti-Influenza A Vir Goat Anti-Influenza A Vir Mouse Anti-Influenza A Vi Mouse Anti-Influenza B Vi Feline Leukemia Virus gp7 Mouse Anti-Influenza B Vi Hepatitis C Virus antibod Goat Anti-Influenza B Vir Hepatitis C Virus antibod Mouse Anti-Influenza B Vi Goat Anti-Influenza A Vir Varicella Zoster Virus (V

Related Pathways

#15286822   // Save this To Up

A simple and cheaper in house varicella zoster virus antibody indirect ELISA.

We have developed a cheaper an simple in house indirect ELISA that uses the live attenuated VZV vaccine as a coating antigen. The alternative ELISA had an agreement of 94% when compared with a commercial VZV ELISA kit. Moreover, our ELISA proved to be more reliable than the kit when assessing true negative samples. By adding a standard serum, we were able to produce results in international units per millilitre. Also, the addition of an extra step with 8M urea allowed the assessment of VZV IgG avidity without excessive costs. The cost per sample to test VZV IgG was 2.7 times cheaper with our ELISA, allowing the testing of many samples without the burden of production of VZV antigen in the laboratory.

2796 related Products with: A simple and cheaper in house varicella zoster virus antibody indirect ELISA.

Anti-Infectious Pancreati Human Anti-E Antigen of H HA (Influenza A Virus Hem Anti-Infectious Pancreati Rabbit Anti-Integrin alph Human interleukin 2(IL-2) Rabbit Anti-Polyprotein(H Human anti-parainfluenza Porcine Transmissible Gas Anti-Infectious Pancreati Rabbit Anti-TNIP2 ABIN2 T Human Varicella zoster vi

Related Pathways

#10774265   // Save this To Up

Immunity to varicella zoster virus in young Israeli adults.

Chickenpox is a highly contagious childhood infection caused by varicella zoster virus, a virus of the herpes family. Although a mild and self-limiting disease in otherwise healthy children, chickenpox can be a complicated and even life-threatening disease in adults, pregnant women and immunosuppressed individuals. Among infants whose mothers had varicella during the first trimester of pregnancy, 2-3% will develop a congenital VZV syndrome that includes a combination of scarring, limb deformation, central nervous system impairment and ocular injury. In 1974, a live attenuated virus vaccine against VZV was developed in Japan and has been thoroughly tested for safety, efficacy and long-term effects. In March 1995 the vaccine was licensed in the U.S. for use in healthy children only.

1464 related Products with: Immunity to varicella zoster virus in young Israeli adults.

Varicella Zoster Virus (V Varicella Zoster Virus (V Human Varicella zoster vi FIV Core Ag, recombinant Varicella Zoster Virus (V Recombinant Tobacco Etch Recombinant Influenza A V Native Influenza HA (A To T-2 Toxin Mycotoxins ELIS Native Influenza A Virus Goat Anti-Influenza A Vir Mouse Anti-Influenza A Vi

Related Pathways